Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023

War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients

Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain
War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )
9 May 2023

War in Ukraine: The impacts and challenges the Polish cancer care system has faced

Prof Jacek Jassem - Medical University of Gdańsk, Gdańsk, Poland
War in Ukraine: The impacts and challenges the Polish cancer care system has faced ( Prof Jacek Jassem - Medical University of Gdańsk, Gdańsk, Poland )
9 May 2023

Collective efforts to combat cancer in Cambodia

Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia
Collective efforts to combat cancer in Cambodia ( Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia )
5 May 2023

Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence

Dr Jeffrey Weber - NYU Langone’s Perlmutter Cancer Center, Newyork, USA
Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence ( Dr Jeffrey Weber - NYU Langone’s Perlmutter Cancer Center, Newyork, USA )
3 May 2023

Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer

Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
2 May 2023

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023

The use of IORT at Universitätsmedizin Mannheim hospital

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023

Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML

Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA
Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML ( Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA )
28 Apr 2023

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Dr Zahid Butt - University of Waterloo, Waterloo, Canada
Applying the syndemic framework to cancer research for effective cancer control in LMICs ( Dr Zahid Butt - University of Waterloo, Waterloo, Canada )
27 Apr 2023

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )
27 Apr 2023